Research & Development



  “我家還少圍牆……”   “大黃弓就這樣了,弓力太大我拉不開,即便是能拉開,也沒有持續作戰的能力,沒什麼用處。”在线播放   劉婆眼中垂淚,哽咽著道︰“老嫗跟女兒兩人如何做良人?老嫗願意在莊子上給小郎做牛做馬一輩子,只求您容老嫗將女兒養在身邊,待到她出嫁的時候恢復她的良人身份。”欧美性爱   盒子是空的,就只是一個藝術品,如果裝了七八根雞腿,雞翅,跟半個豬蹄,大半條紅燒 胡子魚,半盒子白米飯就變得很有生活氣息。   說完話有對雲瑯道︰“這位仁兄乃是中軍府曹椽校尉孟度,為人素來雅達,雲司馬如果想要騎衛,盡管與這位仁兄交涉。”在线a欧美免费   貴者乘車,賤者徒行,這是大漢人顯示身份的一個分界嶺。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo